A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus

Low Blood Concentration of Hydroxychloroquine in Patients With Refractory Cutaneous Lupus Erythematosus

(2012) Anne Cosnes   ARCHIVES OF DERMATOLOGY

Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects

(2012) C. Tang et al.   INTERNAL MEDICINE JOURNAL

Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort

(2012) R Willis et al.   LUPUS

The role of antimalarial agents in the treatment of SLE and lupus nephritis

(2011) Senq-J Lee et al.   Nature Reviews Nephrology

Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus

(2010) Frederick Wolfe et al.   ARTHRITIS CARE & RESEARCH

Use of Hydroxychloroquine to Prevent Thrombosis in Systemic Lupus Erythematosus and in Antiphospholipid Antibody–Positive Patients

(2010) Michelle Petri   Current Rheumatology Reports

Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

(2008) G Ruiz-Irastorza et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints

(2008) G K Bertsias et al.   ANNALS OF THE RHEUMATIC DISEASES